Healthcare Services

Global Cell Based Assays Market Set for Strong Expansion Reaching $54.79 Billion by 2030 at 13.3% CAGR

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Cell Based Assays Market At The End Of The 2026–2030 Forecast Period?

The cell based assays market has experienced rapid expansion in recent years. It is projected to increase from $29.41 billion in 2025 to $33.21 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 12.9%. This historical growth can be linked to several factors, including increasing drug discovery activities, the expansion of in vitro research methodologies, the rising use of cell-based models in basic research, the availability of advanced assay consumables, and an increase in pharmaceutical R&D spending.

The cell based assays market size is projected to experience substantial expansion over the upcoming years. This market is predicted to reach $54.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.3%. This projected growth is driven by factors such as the greater integration of AI-assisted assay analysis, a heightened need for intricate disease modeling, the broadening scope of personalized medicine research, the expanding application of automation in laboratory settings, and larger investments in sophisticated screening platforms. Key developments anticipated during this period encompass the wider embrace of high-throughput cell-based screening, the increasing deployment of automated cell handling systems, a rising call for predictive toxicology assays, the proliferation of label-free cell analysis techniques, and a sharpened emphasis on physiologically relevant cell models.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2546&type=smp

Which Market Drivers Are Supporting The Expansion Of The Cell Based Assays Market?

The increasing sales of biologics are anticipated to boost the cell-based assays market. Biologics, also known as biological products, are medicines originating from living organisms, encompassing a range of items like vaccines, blood and its components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. These assays play a crucial role in biologics by assessing their functionality, potency, safety, and bio-similarity. For example, in October 2024, the Generics and Biosimilars Initiative, a Belgium-based organization that delivers high-quality scientific information on generic and biosimilar medicines, reported that two extra complex drugs, in addition to the nine main biologics, achieved substantial sales in 2023. Specifically, Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both used to treat type 2 diabetes, generated sales of US$14 billion and US$7.2 billion, respectively. Consequently, the growth in electronic payment methods is propelling the cell-based assays market.

What Segment Types Make Up The Cell Based Assays Market?

The cell based assays market covered in this report is segmented –

1) By Product And Service: Consumables, Instruments, Services, Software

2) By Technology: Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies

3) By Application: Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users

Subsegments:

1) By Consumables: Cell Culture Media, Reagents And Kits, Cell Lines, Microplates

2) By Instruments: Microplate Readers, Flow Cytometers, Cell Imaging Systems, Automated Cell Culture Systems

3) By Services: Custom Assay Development, Contract Research Services

4) By Software: Data Analysis Software, Lab Management Software, Simulation And Modeling Software

What Trends Are Advancing Progress In The Cell Based Assays Market?

Leading companies in the cell-based assays market are introducing new platforms, such as cell-based phenotypic assay platforms, to deliver advanced solutions for drug discovery. A cell-based phenotypic assay platform functions as a drug discovery system that assesses cellular responses to compound treatments by integrating advanced imaging and analytical tools, enhanced by artificial intelligence. For example, in June 2024, Sphere Fluidics, a UK-based life sciences R&D company, launched Cyto-Cellect PLUS. Cyto-Cellect PLUS is an intuitive Fluorescence Resonance Energy Transfer (FRET) assay designed to enable researchers to precisely measure IgG productivity with high sensitivity. Expanding upon Sphere Fluidics’ original Cyto-Cellect Human IgG? Detection Kit, this improved version also identifies both IgG ? and ? light chains, thereby increasing its range of applications. The assay exhibits complete compatibility with existing Cyto-Mine® functionality, making single-cell dispensing into 96-well and 384-well plates straightforward. Moreover, it complies with relevant regulatory standards by being free of animal origins, which facilitates its integration into current cell line development processes.

Who Are The Key Players Driving Competition In The Cell Based Assays Market?

Major companies operating in the cell based assays market are Promega Corporation, Bio-Rad Laboratories Inc, PerkinElmer Inc, Abcam plc, Enzo Life Sciences Inc, Cell Signaling Technology Inc, Cisbio International LLC, Eurofins Scientific SE, Charles River Laboratories International Inc, Miltenyi Biotec GmbH, Lonza Group Ltd, Corning Incorporated, Becton Dickinson and Company, Danaher Corporation, GE HealthCare Technologies Inc, BioVision Inc, Biotium Inc, ProQinase GmbH, QGel SA, Cell Biolabs Inc

Read the full cell based assays market report here:

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

How Is The Cell Based Assays Market Distributed Across Key Geographic Regions?

North America was the largest region in the cell-based assays market in 2025. Western Europe was the second largest region in the global cell-based assays market share. The regions covered in the cell based assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Based Assays Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2546&type=smp

Browse Through More Reports Similar to the Global Cell Based Assays Market 2026, By The Business Research Company

Cell And Gene Therapy Manufacturing Services Market

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-market

Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-contract-development-and-manufacturing-organization-cdmo-global-market-report

Cell And Gene Therapy Clinical Trial Services Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-clinical-trial-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795